After 40-year odyssey, first drug for aggressive MS wins FDA approval
(By Ron Winslow for STAT) Forty years ago, one of Dr. Stephen Hauser’s first patients was a young Harvard Law
Read More
Part D/Prescription Drugs
Study: Out-of-pocket EpiPen spending jumps 124% in 7 years
(By Mackenzie Bean for Becker’s Hospital Review) The amount patients pay out-of-pocket for Mylan’s life-saving EpiPen device increased drastically since
Read MoreEnsuring Patients Have Affordable Access to Treatments
At the American Society on Aging annual conference last week in Chicago, IL, Lori Reilly, PhRMA executive vice president of policy,
Read MoreTax Deduction and Medicare
Medicare premiums for Part B, Part D, supplement premiums for added insurance, out-of-pocket costs (such as copayments, prescription expenses) are
Read MoreTwo of the Six Counterclaims against Anthem Inc. Dismissed
U.S. District Judge Edgardo Ramos dismissed Express Scripts’ claim that Anthem breached an implied covenant of good faith and fair
Read MoreFamily Physicians Group Responds to Proposed Changes
The American Academy of Family Physicians (AAFP) in a March 3rd letter to Health and Human Services officials offered detailed comments
Read MoreDoctor Turns Up Possible Treatment For Deadly Sepsis
(By Richard Harris for NPR) It’s hard not to get excited about news of a potentially effective treatment for sepsis, a
Read MoreWith patients demanding experimental drugs, ‘right to try’ is becoming the law of the land
(By Bob Tedeschi for STAT) HARRISBURG, Pa. — To hear Bob Godshall tell it, he has no business being alive. Eleven
Read MoreGAO To Launch Investigation Of FDA’s Orphan Drug Program
(By Sarah Jane Tribble for Kaiser Health News) Acting on a request from three influential U.S. senators, the government’s accountability
Read MoreTrump’s Promise To Rein In Drug Prices Could Open Floodgate To Importation Laws
(By Rachel Bluth for Kaiser Health News) With prescription drug prices soaring and President Donald Trump vowing to take action,
Read More